CENTOGENE NV (CNTG) Stock Price, Quote, News and Overview
NASDAQ:CNTG - Nasdaq - NL0014040206 - Common Stock - Currency: USD
CNTG Quote, Performance and Key Statistics
0.325
-0.02 (-6.23%)
The current stock price of CNTG is 0.325 USD. In the past month the price decreased by -33.52%. In the past year, price decreased by -68.45%.
CNTG Competitors/Peers
Symbol | Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| CI | THE CIGNA GROUP | 12.07 | 89.50B | ||
| CVS | CVS HEALTH CORP | 12.42 | 84.95B | ||
| DGX | QUEST DIAGNOSTICS INC | 18.16 | 18.18B | ||
| LH | LABCORP HOLDINGS INC | 14.9 | 18.17B | ||
| FMS | FRESENIUS MEDICAL CARE-ADR | 12.78 | 13.88B | ||
| DVA | DAVITA INC | 14.74 | 11.20B | ||
| BTSGU | BRIGHTSPRING HEALTH SERV - BTSG 6 3/4 02/01/27 | 110.15 | 10.60B | ||
| CHE | CHEMED CORP | 25.14 | 8.50B | ||
| HIMS | HIMS & HERS HEALTH INC | 50.43 | 6.05B | ||
| CRVL | CORVEL CORP | 27.53 | 5.91B | ||
| GH | GUARDANT HEALTH INC | N/A | 5.55B | ||
| OPCH | OPTION CARE HEALTH INC | 26.25 | 5.26B |
Related stock screener links
About CNTG
Company Profile
Centogene NV is a commercial-stage company, which focuses on rare diseases that transform real-world clinical and genetic data into actionable information for patients, physicians, and pharmaceutical companies. The company is headquartered in Rostock, Mecklenburg-Vorpommern and currently employs 493 full-time employees. The company went IPO on 2019-11-07. The firm focuses on rare diseases, transforming clinical and genetic data into actionable information for patients, physicians and pharmaceutical companies. The firm's platform includes epidemiological, phenotypic, and genetic data reflecting a global population, as well as a biobank of blood samples from these patients. The firm's pharmaceutical segment provides a variety of services to its pharmaceutical partners, including early patient recruitment and identification, epidemiological insights, biomarker discovery, and patient monitoring. The firm's Clinical Diagnostics segment provides targeted genetic sequencing and diagnostic services to patients through its distribution partners and customers, which are typically physicians, laboratories or hospitals.
Company Info
CENTOGENE NV
Am Strande 7
Rostock MECKLENBURG-VORPOMMERN 18055 DE
CEO: Andrin Oswald
Employees: 493
Company Website: https://www.centogene.com/
Phone: 4938180113400
CENTOGENE NV / CNTG FAQ
What is the stock price of CENTOGENE NV today?
The current stock price of CNTG is 0.325 USD. The price decreased by -6.23% in the last trading session.
What is the ticker symbol for CENTOGENE NV stock?
The exchange symbol of CENTOGENE NV is CNTG and it is listed on the Nasdaq exchange.
On which exchange is CNTG stock listed?
CNTG stock is listed on the Nasdaq exchange.
What is the price forecast or stock price prediction for CENTOGENE NV stock?
7 analysts have analysed CNTG and the average price target is 1.53 USD. This implies a price increase of 370.77% is expected in the next year compared to the current price of 0.325. Check the CENTOGENE NV stock analysts ratings, price target forecast and up-and down grades for more detailed information.
What is CENTOGENE NV worth?
CENTOGENE NV (CNTG) has a market capitalization of 8.97M USD. This makes CNTG a Nano Cap stock.
How many employees does CENTOGENE NV have?
CENTOGENE NV (CNTG) currently has 493 employees.
What are the support and resistance levels for CENTOGENE NV (CNTG) stock?
CENTOGENE NV (CNTG) has a resistance level at 0.35. Check the full technical report for a detailed analysis of CNTG support and resistance levels.
Is CENTOGENE NV (CNTG) expected to grow?
The Revenue of CENTOGENE NV (CNTG) is expected to grow by 22.37% in the next year. Check the estimates tab for more information on the CNTG EPS, Sales, EBIT and EBITDA future analyst estimates.
Should I buy CENTOGENE NV (CNTG) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of CNTG, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of CNTG, evaluating the profitability, health, valuation and growth aspects
- CENTOGENE NV (CNTG) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- CENTOGENE NV (CNTG) Sales and EPS estimates to see what analysts future expectations are.
- CENTOGENE NV (CNTG) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- CENTOGENE NV (CNTG) Insider and Institutional Ownership to learn about the owners and their transactions.
- CENTOGENE NV (CNTG) Stock Chart to make your own analysis
- CENTOGENE NV (CNTG) Latest news and press-releases to stay up to date.
Does CENTOGENE NV (CNTG) stock pay dividends?
CNTG does not pay a dividend.
When does CENTOGENE NV (CNTG) report earnings?
CENTOGENE NV (CNTG) will report earnings on 2024-09-04.
What is the Price/Earnings (PE) ratio of CENTOGENE NV (CNTG)?
CENTOGENE NV (CNTG) does not have a PE ratio as the earnings reported over the last twelve months were negative (-1.39).
CNTG Technical Analysis
CNTG Fundamental Analysis
ChartMill assigns a fundamental rating of 1 / 10 to CNTG. CNTG has a bad profitability rating. Also its financial health evaluation is rather negative.
CNTG Financial Highlights
Over the last trailing twelve months CNTG reported a non-GAAP Earnings per Share(EPS) of -1.39. The EPS decreased by -6.92% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -46.05% | ||
| ROE | N/A | ||
| Debt/Equity | N/A |
CNTG Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 83% to CNTG. The Buy consensus is the average rating of analysts ratings from 7 analysts.
For the next year, analysts expect an EPS growth of 39.38% and a revenue growth 22.37% for CNTG